Cas no 929971-95-9 (6,7-dimethoxycinnoline-3-carboxylic acid)

6,7-Dimethoxycinnoline-3-carboxylic acid is a cinnoline derivative characterized by its dimethoxy substitution at the 6 and 7 positions and a carboxylic acid functional group at the 3-position. This compound serves as a versatile intermediate in organic synthesis, particularly in the development of pharmaceuticals and agrochemicals. Its structural features, including the electron-rich dimethoxy groups and the reactive carboxylic acid moiety, make it valuable for further functionalization, such as amidation or esterification. The cinnoline core contributes to potential biological activity, often explored in medicinal chemistry for its heterocyclic properties. The compound is typically handled under standard laboratory conditions, with purity and stability being key considerations for research applications.
6,7-dimethoxycinnoline-3-carboxylic acid structure
929971-95-9 structure
Product Name:6,7-dimethoxycinnoline-3-carboxylic acid
CAS No:929971-95-9
MF:C11H10N2O4
MW:234.208102703094
MDL:MFCD09040699
CID:3155329
PubChem ID:16227993
Update Time:2025-06-30

6,7-dimethoxycinnoline-3-carboxylic acid Chemical and Physical Properties

Names and Identifiers

    • 6,7-dimethoxycinnoline-3-carboxylic acid
    • 929971-95-9
    • EMB97195
    • AKOS000117974
    • 6,7-dimethoxycinnoline-3-carboxylicacid
    • EN300-27678
    • Z235344949
    • MDL: MFCD09040699
    • Inchi: 1S/C11H10N2O4/c1-16-9-4-6-3-8(11(14)15)13-12-7(6)5-10(9)17-2/h3-5H,1-2H3,(H,14,15)
    • InChI Key: PBTKNSLLXQBHGG-UHFFFAOYSA-N
    • SMILES: O(C)C1C(=CC2=C(C=C(C(=O)O)N=N2)C=1)OC

Computed Properties

  • Exact Mass: 234.06405680Da
  • Monoisotopic Mass: 234.06405680Da
  • Isotope Atom Count: 0
  • Hydrogen Bond Donor Count: 1
  • Hydrogen Bond Acceptor Count: 6
  • Heavy Atom Count: 17
  • Rotatable Bond Count: 3
  • Complexity: 287
  • Covalently-Bonded Unit Count: 1
  • Defined Atom Stereocenter Count: 0
  • Undefined Atom Stereocenter Count : 0
  • Defined Bond Stereocenter Count: 0
  • Undefined Bond Stereocenter Count: 0
  • XLogP3: 1
  • Topological Polar Surface Area: 81.5?2

6,7-dimethoxycinnoline-3-carboxylic acid Pricemore >>

Related Categories No. Product Name Cas No. Purity Specification Price update time Inquiry
TRC
D484820-10mg
6,7-Dimethoxycinnoline-3-carboxylic Acid
929971-95-9
10mg
$ 70.00 2022-06-05
TRC
D484820-50mg
6,7-Dimethoxycinnoline-3-carboxylic Acid
929971-95-9
50mg
$ 210.00 2022-06-05
TRC
D484820-100mg
6,7-Dimethoxycinnoline-3-carboxylic Acid
929971-95-9
100mg
$ 340.00 2022-06-05
SHANG HAI HAO HONG Biomedical Technology Co., Ltd.
1555232-500mg
6,7-Dimethoxycinnoline-3-carboxylic acid
929971-95-9 98%
500mg
¥7540.00 2024-04-25
SHANG HAI HAO HONG Biomedical Technology Co., Ltd.
1555232-1g
6,7-Dimethoxycinnoline-3-carboxylic acid
929971-95-9 98%
1g
¥7550.00 2024-04-25
SHANG HAI HAO HONG Biomedical Technology Co., Ltd.
1555232-5g
6,7-Dimethoxycinnoline-3-carboxylic acid
929971-95-9 98%
5g
¥24222.00 2024-04-25
SHANG HAI HAO HONG Biomedical Technology Co., Ltd.
1555232-10g
6,7-Dimethoxycinnoline-3-carboxylic acid
929971-95-9 98%
10g
¥38714.00 2024-04-25
A2B Chem LLC
AV26099-50mg
6,7-Dimethoxycinnoline-3-carboxylic acid
929971-95-9 90%
50mg
$248.00 2024-07-18
A2B Chem LLC
AV26099-100mg
6,7-Dimethoxycinnoline-3-carboxylic acid
929971-95-9 90%
100mg
$352.00 2024-07-18
A2B Chem LLC
AV26099-250mg
6,7-Dimethoxycinnoline-3-carboxylic acid
929971-95-9 90%
250mg
$489.00 2024-07-18

Additional information on 6,7-dimethoxycinnoline-3-carboxylic acid

Introduction to 6,7-dimethoxycinnoline-3-carboxylic acid (CAS No. 929971-95-9)

6,7-dimethoxycinnoline-3-carboxylic acid, identified by the Chemical Abstracts Service Number (CAS No.) 929971-95-9, is a heterocyclic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal research. This compound belongs to the cinnoline family, a class of nitrogen-containing heterocycles that exhibit a broad spectrum of biological activities. The structural features of 6,7-dimethoxycinnoline-3-carboxylic acid, particularly the presence of methoxy groups at the 6th and 7th positions of the cinnoline ring and a carboxylic acid moiety at the 3rd position, contribute to its unique chemical properties and potential pharmacological applications.

The synthesis and characterization of 6,7-dimethoxycinnoline-3-carboxylic acid have been extensively studied due to its significance as a building block in drug discovery. The compound can be synthesized through various chemical pathways, including cyclization reactions and functional group transformations. Advanced spectroscopic techniques such as nuclear magnetic resonance (NMR) spectroscopy, mass spectrometry (MS), and X-ray crystallography have been employed to elucidate its molecular structure and confirm its identity. These studies have revealed that 6,7-dimethoxycinnoline-3-carboxylic acid possesses a stable framework with well-defined electronic and steric properties, making it a valuable intermediate in organic synthesis.

In recent years, 6,7-dimethoxycinnoline-3-carboxylic acid has been explored for its potential therapeutic applications in several areas of medicine. One of the most promising applications is in the development of anticancer agents. Research has demonstrated that derivatives of cinnoline exhibit inhibitory effects on various cancer cell lines by interfering with key cellular processes such as DNA replication and cell cycle progression. The methoxy groups in 6,7-dimethoxycinnoline-3-carboxylic acid may play a crucial role in modulating these effects by enhancing binding affinity to target proteins. Furthermore, studies have shown that modifications of the carboxylic acid group can lead to the development of prodrugs with improved solubility and bioavailability.

Another area where 6,7-dimethoxycinnoline-3-carboxylic acid has shown promise is in the treatment of infectious diseases. Emerging evidence suggests that cinnoline derivatives possess antimicrobial properties against a range of pathogens, including bacteria and fungi. The structural motif of 6,7-dimethoxycinnoline-3-carboxylic acid may interact with essential bacterial enzymes or membrane components, disrupting vital metabolic pathways. This has opened up new avenues for developing novel antibiotics and antifungal agents to combat drug-resistant strains.

The pharmacokinetic profile of 6,7-dimethoxycinnoline-3-carboxylic acid is also an important consideration in drug development. Studies have investigated its absorption, distribution, metabolism, and excretion (ADME) properties using preclinical models. The presence of hydrophilic functional groups such as the carboxylic acid moiety influences its solubility and permeability across biological membranes. Optimization of these properties can enhance therapeutic efficacy while minimizing side effects. Additionally, computational modeling techniques have been employed to predict the binding interactions between 6,7-dimethoxycinnoline-3-carboxylic acid and biological targets, providing insights into its mechanism of action.

From a chemical biology perspective, 6,7-dimethoxycinnoline-3-carboxylic acid serves as a versatile scaffold for designing small molecule probes to study biological processes. Its unique structural features allow for selective targeting of specific enzymes or receptors involved in disease pathways. For instance, researchers have utilized derivatives of this compound to develop inhibitors of kinases and other enzymes implicated in cancer signaling networks. By modulating these enzymatic activities, it may be possible to develop therapeutic strategies that restore normal cellular function.

The industrial significance of 6,7-dimethoxycinnoline-3-carboxylic acid extends beyond academic research into commercial applications. Pharmaceutical companies are increasingly investing in the development of novel heterocyclic compounds due to their diverse biological activities. The synthetic accessibility and functional diversity of 6,7-dimethoxycinnoline-3-carboxylic acid make it an attractive candidate for further development into marketable drugs. Collaborative efforts between academia and industry are essential to translate laboratory findings into clinical trials and eventually bring new treatments to patients in need.

In conclusion,6,7-dimethoxycinnoline-3-carboxylic acid (CAS No. 929971-95-9) is a structurally interesting compound with significant potential in pharmaceutical research and drug development. Its unique chemical properties and biological activities make it a valuable tool for exploring new therapeutic strategies across various medical disciplines. Continued investigation into its synthesis, pharmacology, and industrial applications will further solidify its role as a key player in modern medicinal chemistry.

Recommended suppliers
Jinan Hanyu Chemical Co.,Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Jinan Hanyu Chemical Co.,Ltd.
Jiangxi Boyang Pharmaceutical Chemical Co., Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Jiangxi Boyang Pharmaceutical Chemical Co., Ltd
Jinta Yudi Pharmaceutical Technology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Jinta Yudi Pharmaceutical Technology Co., Ltd.
PRIBOLAB PTE.LTD
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
PRIBOLAB PTE.LTD
Shenzhen GeneSeqTools Bioscience & Technology Co. Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Shenzhen GeneSeqTools Bioscience & Technology Co. Ltd.